![Rick van den Toorn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rick van den Toorn
Keine laufenden Positionen mehr
Profil
Rick van den Toorn worked as a Director at Stem Cell Therapy International, Inc. and AmStem Corp.
in 2010.
Ehemalige bekannte Positionen von Rick van den Toorn
Unternehmen | Position | Ende |
---|---|---|
AmStem Corp.
![]() AmStem Corp. Pharmaceuticals: OtherHealth Technology AmStem Corp. researches and develops stem cell transplantation therapy and regenerative medicine. The company owns cord blood stem cell bank in Korea. The company was founded on December 28, 1992 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 16.11.2010 |
Stem Cell Therapy International, Inc.
![]() Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Stem Cell Therapy International, Inc. is a surgical procedure that has been used successfully for 70+ years as a treatment of many diseases for which modern medicine has had no therapy, or in which 'state-of-art' therapies stopped being effective. A documented 5 millions of patients have been so treated worldwide to-date, evidenced by over 120,000 publications in MEDLINE amongst others. SCT is approved for use by the German authorities and the EU. | Direktor/Vorstandsmitglied | 23.02.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Stem Cell Therapy International, Inc.
![]() Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Stem Cell Therapy International, Inc. is a surgical procedure that has been used successfully for 70+ years as a treatment of many diseases for which modern medicine has had no therapy, or in which 'state-of-art' therapies stopped being effective. A documented 5 millions of patients have been so treated worldwide to-date, evidenced by over 120,000 publications in MEDLINE amongst others. SCT is approved for use by the German authorities and the EU. | Commercial Services |
AmStem Corp.
![]() AmStem Corp. Pharmaceuticals: OtherHealth Technology AmStem Corp. researches and develops stem cell transplantation therapy and regenerative medicine. The company owns cord blood stem cell bank in Korea. The company was founded on December 28, 1992 and is headquartered in San Francisco, CA. | Health Technology |